| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 800.0K | $1.03M | - | |
| Other | 400.0K | $516.0K | - | |
| Other | 30.0K | $38.7K | - | |
| Dir | 29.8K | $38.4K | - | |
| Dir | 29.2K | $37.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | Smith Stan | Director | Buy | 208 | $4.25 | $884.00 | - | -45.7% | -63.7% | |
| Feb 10, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 343 | $4.24 | $1,454.32 | - | -42.3% | -66.5% | |
| Feb 10, 2023 | Smith Stan | Director | Buy | 337 | $4.25 | $1,432.25 | - | -42.3% | -66.5% | |
| Jan 26, 2023 | Smith Stan | Director | Buy | 236 | $4.24 | $1,000.73 | - | -46.2% | -67.7% | |
| Jan 13, 2023 | Luput Cristian | Director | Buy | 504 | $3.88 | $1,955.52 | +0.2% | -9.5% | -72.4% | |
| Jan 4, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,266 | $3.68 | $4,658.88 | +0.2% | -1.7% | -66.7% | |
| Jan 3, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 2,734 | $3.62 | $9,894.36 | +0.2% | +0.8% | -67.5% | |
| Dec 30, 2022 | Smith Stan | Director | Buy | 1,971 | $3.49 | $6,883.79 | +0.2% | -2.0% | -66.7% | |
| Dec 28, 2022 | Smith Stan | Director | Buy | 1,870 | $3.40 | $6,358.58 | +0.2% | +2.0% | -63.7% | |
| Dec 23, 2022 | Smith Stan | Director | Buy | 1,712 | $3.40 | $5,825.99 | +0.2% | -8.4% | -67.2% |